Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing.

Source:http://linkedlifedata.com/resource/pubmed/id/15108250

Download in:

View as

General Info

PMID
15108250